Neurotensin receptors in human neoplasms: High incidence in Ewing's sarcomas

International Journal of Cancer

Volumn 82, Issue 2, 1999, Pages 213-218

  Reubi, Jean Claude ^a   Waser, Beatrice ^a   Schaer, Jean Claude ^a   Laissue, Jean A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTENSIN RECEPTOR;

ARTICLE; AUTORADIOGRAPHY; CANCER GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EWING SARCOMA; FEEDBACK SYSTEM; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY;

ANIMALS; BONE NEOPLASMS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; NEUROTENSIN; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; PIPERIDINES; PYRAZOLES; QUINOLINES; RATS; RECEPTORS, NEUROTENSIN; RNA, MESSENGER; RNA, NEOPLASM; SARCOMA, EWING'S;

EID: 0032975129     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990719)82:2<213::AID-IJC11>3.0.CO;2-8     Document Type: Article

References (24)

1. Bozou, J.C., AMAR, S., VINCENT, J.P. and KITABGI, P., Neurotensin mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP binding component of adenylate cyclase. Mol. Pharmacol., 29, 489-496 (1986).
2. CAMBY, I., SALMON, I., BOURDEL, E., NAGY, N., DANGUY, A., BROTCHI, J., PASTEELS, J., MARTINEZ, J. and KISS, R., Neurotensin-mediated effects on astrocytic tumour cell proliferation. Neuropeptides, 30, 133-139 (1996).
3. GULLY, D. and 17 OTHERS, Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. nat. Acad. Sci. (Wash.), 90, 65-69 (1993).
4. GULLY, D. and 15 OTHERS, Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J. Pharmacol. exp. Ther., 280, 802-812 (1997).
5. IWASE, K., EVERS, B.M., HELLMICH, M.R., KIM, H.J., HIGASHIDE, S., GULLY, D., THOMPSON, J.C. and TOWNSEND, C.M., JR., Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692. Cancer, 79, 1787-1793 (1997).
6. KITABGI, P., ROSTÈNE, W., DUSSAILLANT, M., SCHOTTE, A., LADURON, P.M. and VINCENT, J., Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution. Europ. J. Pharmacol., 140, 285-293 (1987).
7. KRENNING, E.P., KWEKKEBOOM, D.J., PAUWELS, S., KVOLS, L.K. and REUBI, J.C., Somatostatin receptor scintigraphy. Nucl. Med. Annual 1995, pp. 1-50 (1995).
8. MOODY, T.W. and CUTTITTA, F., Growth factor and peptide receptors in small cell lung cancer. Life Sci., 52, 1161-1173 (1993).
9. OTTE, A., MUELLER-BRAND, J., DELLAS, S., NITZSCHE, E.U., HERRMANN, R. and MAECKE, H.R., Yttrium-90-labelled somatostatin-analogue for cancer treatment. Lancet, 351, 417-418 (1998).
10. PRZEDBORSKI, S., LEVIVIER, M. and CADET, J.L., Neurotensin receptors in human meningiomas. Ann. Neurol., 30, 650-654 (1991).
11. REUBI, J.C., In vitro identification of vasoactive intestinal peptide receptors in human tumours: implications for tumour imaging. J. nucl. Med., 36, 1846-1853 (1995).
12. REUBI, J.C., Relevance of somatostatin receptors and other peptide receptors in pathology. Endocr. Pathol., 8, 11-20 (1997).
13. REUBI, J.C., KVOLS, L.K., WASER, B., NAGORNEY, D., HEITZ, P.U., CHARBONEAU, J.W., READING, C.C. and MOERTEL, C., Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res., 50, 5969-5977 (1990).
14. REUBI, J.C., SCHAER, J.C. and WASER, B., Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumours. Cancer Res., 57, 1377-1386 (1997).
15. REUBI, J.C., SCHAER, J.C., WASER, B. and MENGOD, G., Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSTR3 mRNAs in primary human tumours using in situ hybridization. Cancer Res., 54, 3455-3459 (1994).
16. REUBI, J.C., WASER, B., FRIESS, H., BÜCHLER, M.W. and LAISSUE, J.A., Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut, 42, 546-550 (1998).
17. REUBI, J.C., WASER, B., LAISSUE, J.A. and GEBBERS, J., Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumours: in vitro identification. Cancer Res., 56, 1922-1931 (1996).
18. REUBI, J.C., WASER, B., SCHMASSMANN, A. and LAISSUE, J.A., Receptors for cholecystokinin, neurotensin, somatostatin, and VIP in gastrointestinal adenocarcinoma samples: where are they really located? Int. J. Cancer (1999). (In press).
19. SCOTLANDI, K., SERRA, M., MANARA, M.C., BENINI, S., SARTI, M., MAURICI, D., LOLLINI, P.L., PICCI, P., BERTONI, F. and BALDINI, N., Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour. Hum. Pathol., 27, 408-416 (1996).
20. SEETHALAKSHMI, L., MITRA, S.P., DOBNER, P.R., MENON, M. and CARRAWAY, R.E., Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate, 31, 183-192 (1997).
21. SHULKES, A., In: J.H. Walsh and G.J. Dockray (eds.), Gut peptides: biochemistry and physiology, pp. 371-388, Raven Press, New York (1994).
22. TERRIERE, D., CHAVATTE, K., CEUSTERS, M., TOURWÉ, D. and MERTENS, J., Radiosynthesis of new radio neurotensin(8-13) analogues. J. Labelled Compounds Radiopharm., 151, 19-27 (1998).
23. YAMADA, M., YAMADA, M., LOMBET, A., FORGEZ, P. and ROSTÈNE, W., Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells. Life Sci., 62, 375-380 (1998).
24. ZEYTINOGLU, F.N., GABEL, R.F., TASHJIAN, A.H., HAMMER, R.A. and LEEMAN, S.E., Characterization of neurotensin production by a line of rat medullary thyroid carcinoma cells. Proc. nat. Acad. Sci. (Wash.), 77, 3741-3745 (1980).